Phase I dose-finding study of pazopanib in hepatocellular carcinoma: evaluation of early efficacy, pharmacokinetics, and pharmacodynamics. [electronic resource]
Producer: 20120120Description: 6914-23 p. digitalISSN:- 1557-3265
- Adult
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Carcinoma, Hepatocellular -- blood
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Female
- Humans
- Indazoles
- Liver Neoplasms -- blood
- Male
- Middle Aged
- Pyrimidines -- administration & dosage
- Sulfonamides -- administration & dosage
- alpha-Fetoproteins -- metabolism
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.